APA (7th ed.) Citation

O, E., Y, H., B, M., R, V. D., K, L., J, W., . . . E, D. (2025). Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasis. Infection, 53(3), 1155. https://doi.org/10.1007/s15010-024-02448-x

Chicago Style (17th ed.) Citation

O, Elkayal, Hoffert Y, Mertens B, Van Daele R, Lagrou K, Wauters J, Spriet I, and Dreesen E. "Anidulafungin Exposure and Population Pharmacokinetics in Critically Ill Patients with Invasive Candidiasis." Infection 53, no. 3 (2025): 1155. https://doi.org/10.1007/s15010-024-02448-x.

MLA (9th ed.) Citation

O, Elkayal, et al. "Anidulafungin Exposure and Population Pharmacokinetics in Critically Ill Patients with Invasive Candidiasis." Infection, vol. 53, no. 3, 2025, p. 1155, https://doi.org/10.1007/s15010-024-02448-x.